Related Experiment Videos
Induction of the pro-myelocytic leukaemia gene by type I and type II interferons
M Heuser1, H van der Kuip, B Falini
1III. Medical Department, Johannes-Gutenberg-University Mainz, Germany.
Abstract:
The physiological role of the pro-myelocytic leukaemia (PML) gene product is poorly defined. Among other functions, PML is involved in haematopoietic differentiation and in control of cell growth and tumorigenesis. We investigated the regulation of human PML expression by interferons (IFNs) and IL-1 in various human haematopoietic lines (U937, THP1, HL60, NB4), in human diploid fibroblasts and in human peripheral blood leukocytes. Cytokine-induced modulation of PML expression was assessed by Northern blot analyses, flow cytometry studies and in situ immunolabelling. Our data show that IFNs and IL-1 upregulate PML transcript and protein expression in a time and dose-dependent manner. In situ immunolabelling revealed that upregulation of protein expression by IFN-alpha is a consequence of a marked increase in both the number and the intensity of the staining of so-called PML nuclear bodies. Our data suggest that stimulation of PML expression by interferons and IL-1 may account for upregulation of PML proteins observed in inflammatory tissues and in proliferative states.
Insights
Interferons (IFNs) and IL-1 increase pro-myelocytic leukaemia (PML) gene expression in blood cells. This cytokine-induced upregulation of PML protein and nuclear bodies may play a role in inflammatory and proliferative conditions.
Area of Science:
- Molecular Biology
- Cell Biology
- Immunology
Background:
- The physiological role of the pro-myelocytic leukaemia (PML) gene product is not well understood.
- PML is implicated in hematopoietic differentiation, cell growth control, and tumorigenesis.
Purpose of the Study:
- To investigate the regulation of human PML gene expression by interferons (IFNs) and IL-1.
- To determine the effect of these cytokines on PML transcript and protein levels in various human cell types.
Main Methods:
- Northern blot analyses to assess transcript levels.
- Flow cytometry and in situ immunolabelling to evaluate protein expression and localization.
- Experiments conducted on human hematopoietic cell lines (U937, THP1, HL60, NB4), fibroblasts, and peripheral blood leukocytes.
Main Results:
- IFNs and IL-1 significantly upregulate both PML transcript and protein expression in a time- and dose-dependent manner.
- IFN-alpha treatment leads to increased numbers and intensity of PML nuclear bodies.
- Cytokine-induced modulation of PML expression was observed across tested hematopoietic and non-hematopoietic cell types.
Conclusions:
- Interferons and IL-1 are potent regulators of human PML gene expression.
- The observed upregulation of PML by cytokines may contribute to the elevated PML protein levels found in inflammatory tissues and proliferative states.
- PML nuclear body dynamics are influenced by cytokine signaling, suggesting a role in cellular responses to inflammation and proliferation.